Woman gets first trachea transplant without drugs
By Michael Kahn
LONDON (Reuters) - A Colombian woman has received the world’s first tailor-made trachea transplant, grown by seeding a donor organ with her own stem cells to prevent her body rejecting it, an international research team reported on Wednesday.
The success of the operation, performed in June using tissue generated from the woman’s own bone marrow, raises the prospect that transplanting other organs may be possible without drugs to dampen the immune system, they said.
Doctors work hard to match tissue type when transplanting organs so that the body does not completely reject the new organ, but patients usually have to take immunosuppressants for the rest of their lives.
“The probability this lady will have a rejection is almost zero percent,” Dr. Paolo Macchiarini, head of thoracic surgery at the Hospital Clinic, Barcelona who performed the transplant, told a news conference.
“The patient is enjoying a normal life with no signs of rejection after four months.”
Claudia Castillo sought help after a case of tuberculosis destroyed part of her trachea — the windpipe connected to the lungs — and left her with breathing difficulties, prone to infections and unable to care for her two children.
The 30-year-old’s only option other than the experimental surgery was for doctors to remove part of her lung — a choice that would have seriously degraded her quality of life, the researchers said.
“It isn’t just an issue of life, it is an issue of quality of life,” said Martin Birchall, a surgeon at the University of Bristol, who helped treat Castillo.
‘HYBRID ORGAN’
After finding a donor, the researchers first depleted the transplanted trachea of the donor’s cells and then obtained bone marrow stem cells from Castillo they grew into cartilage cells.
Next, the team seeded these cells on the outside of the donor trachea using a device developed at Milan Polytechnic in Italy that incubated the cells. The researchers used the same device to make epithelial cells to construct the lining of the trachea.
This created a hybrid organ in a lab that Castillo’s body would identify as its own and make immunosupressant drugs unnecessary, the researchers said.
Finally, the team grafted a 5 cm (1.97 inch) piece of the trachea onto Castillo’s damaged left main bronchus, which connects the main windpipe to the left lung.
Castillo, who lives in Spain, had no complications from the surgery and left the hospital after 10 days. She is returning to normal activities and even called her doctors from a night club to say she had been out dancing all night, the researchers said.
“We believe this success has proved we are on the verge of a new age in surgical care,” said Birchall, who predicted the technique could be applied to other hollow organs similar in structure, such as the bowel, bladder and reproductive tract.
(Reporting by Michael Kahn; Editing by Maggie Fox and Mark Trevelyan)
--------------------------------------------------------------------------------------------Related Posts:
BERLIN (Reuters) - A bone marrow transplant using stem cells from a donor with natural genetic resistance to the AIDS virus has left an HIV patient free of infection for nearly two years, German researchers. The patient, an American living in Berlin, was infected with the human immunodeficiency virus that causes AIDS and also had leukemia.
Full Post: Bone marrow transplant suppresses AIDS in patient
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - An organ allocation policy that puts the sickest patients first in line to receive available donor livers for transplantation has created some unintended consequences for those patients low on the organ wait list, research suggests. Since the new donor organ allocation system was implemented in early 2002, there has been a
Full Post: Policy has changed how organs are allocated
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - Advanced donor age, per se, does not adversely affect the transplant recipient or the survival of the organ after liver transplantation, according to a report in the Journal of the American College of Surgeons. Previous reports have indicated that the age of the donor — older than 60 years - contributes
Full Post: Liver transplants from elderly donors are safe
--------------------------------------------------------------------------------------------
BRUSSELS (Reuters) - Europe’s health chief proposed ways Monday to improve availability of transplant organs across frontiers and reduce the number of people who can die while awaiting an operation. Organ shortage is a common problem in all European Union countries, with some 56,000 patients waiting for a suitable organ donor across the EU’s 27 member
Full Post: EU looks at increasing supply of transplant organs
--------------------------------------------------------------------------------------------
By Michael Kahn LONDON (Reuters) - A novel drug combination using Genzyme Corp’s Mozobil shows it may be possible to spur bone marrow into releasing extra adult stem cells into the bloodstream to repair the heart and broken bones, researchers said on Thursday. The study of mice raises hope that researchers could use the same technique to
Full Post: New drug combo may boost stem cell production